tara-002,ipilimumab,nivolumab,cabozantinib
exelixis,protara therap,bms
['advanced 1', 'nivo', 'rcc,(-irccs),(-srcc),(-urcc)', 'cosmic-313', ' ipi ', ' cabo ']
dr choieiri presents positive pfs results from cosmic-313 for cabo added to ipi nivo immuno doublet in advanced 1l arcc (intermediate and poor risk) #esmo22 
Regional Cancer Research Director @CleveClinicFl #Scientist #Immune #Oncology #Epigenetics #Cancer #Sensitisation #TIME #StayPositive. Tweets are mine.